SEOM clinical guidelines in advanced and recurrent breast cancer (2018)

Although the metastasic breast cancer is still an incurable disease, recent advances have increased signifcantly the time to progression and the overall survival. However, too much information has been produced in the last 2 years, so a well-based guideline is a valuable document in treatment decisi...

Full description

Bibliographic Details
Authors: Chacón López-Muñiz, J. I., Cruz Merino, Luis de la, Gavilá Gregori, J., Martínez Dueñas, E., Oliveira, M., Seguí Palmer, M. A., Álvarez López, I., Antolin Novoa, S., Bellet Ezquerra, M., López-Tarruella Cobo, S.
Format: article
Status:Published version
Publication Date:2019
Country:España
Institution:Universidad de Sevilla (US)
Repository:idUS. Depósito de Investigación de la Universidad de Sevilla
OAI Identifier:oai:idus.us.es:11441/156029
Online Access:https://hdl.handle.net/11441/156029
https://doi.org/10.1007/s12094-018-02010-w
Access Level:Open access
Keyword:Advanced
Loco-regional recurrence
Breast cancer
SEOM
Guidelines
id ES_8cbcb22350be2ab6bcd2f727338ff7d3
oai_identifier_str oai:idus.us.es:11441/156029
network_acronym_str ES
network_name_str España
repository_id_str
spelling SEOM clinical guidelines in advanced and recurrent breast cancer (2018)Chacón López-Muñiz, J. I.Cruz Merino, Luis de laGavilá Gregori, J.Martínez Dueñas, E.Oliveira, M.Seguí Palmer, M. A.Álvarez López, I.Antolin Novoa, S.Bellet Ezquerra, M.López-Tarruella Cobo, S.AdvancedLoco-regional recurrenceBreast cancerSEOMGuidelinesAlthough the metastasic breast cancer is still an incurable disease, recent advances have increased signifcantly the time to progression and the overall survival. However, too much information has been produced in the last 2 years, so a well-based guideline is a valuable document in treatment decision making. The SEOM guidelines are intended to make evidence-based recommendations on how to manage patients with advanced and recurrent breast cancer to achieve the best patient outcomes based on a rational use of the currently available therapies. To assign a level of certainty and a grade of recommendation the United States Preventive Services Task Force guidelines methodology was selected as reference.SpringerMedicinaCTS151: Bioquímica médica2019info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfapplication/pdfhttps://hdl.handle.net/11441/156029https://doi.org/10.1007/s12094-018-02010-wreponame:idUS. Depósito de Investigación de la Universidad de Sevillainstname:Universidad de Sevilla (US)InglésClinical and Translational Oncology, 21 (1), 31-45.https://link.springer.com/article/10.1007/s12094-018-02010-winfo:eu-repo/semantics/openAccessoai:idus.us.es:11441/1560292026-06-17T12:51:07Z
dc.title.none.fl_str_mv SEOM clinical guidelines in advanced and recurrent breast cancer (2018)
title SEOM clinical guidelines in advanced and recurrent breast cancer (2018)
spellingShingle SEOM clinical guidelines in advanced and recurrent breast cancer (2018)
Chacón López-Muñiz, J. I.
Advanced
Loco-regional recurrence
Breast cancer
SEOM
Guidelines
title_short SEOM clinical guidelines in advanced and recurrent breast cancer (2018)
title_full SEOM clinical guidelines in advanced and recurrent breast cancer (2018)
title_fullStr SEOM clinical guidelines in advanced and recurrent breast cancer (2018)
title_full_unstemmed SEOM clinical guidelines in advanced and recurrent breast cancer (2018)
title_sort SEOM clinical guidelines in advanced and recurrent breast cancer (2018)
dc.creator.none.fl_str_mv Chacón López-Muñiz, J. I.
Cruz Merino, Luis de la
Gavilá Gregori, J.
Martínez Dueñas, E.
Oliveira, M.
Seguí Palmer, M. A.
Álvarez López, I.
Antolin Novoa, S.
Bellet Ezquerra, M.
López-Tarruella Cobo, S.
author Chacón López-Muñiz, J. I.
author_facet Chacón López-Muñiz, J. I.
Cruz Merino, Luis de la
Gavilá Gregori, J.
Martínez Dueñas, E.
Oliveira, M.
Seguí Palmer, M. A.
Álvarez López, I.
Antolin Novoa, S.
Bellet Ezquerra, M.
López-Tarruella Cobo, S.
author_role author
author2 Cruz Merino, Luis de la
Gavilá Gregori, J.
Martínez Dueñas, E.
Oliveira, M.
Seguí Palmer, M. A.
Álvarez López, I.
Antolin Novoa, S.
Bellet Ezquerra, M.
López-Tarruella Cobo, S.
author2_role author
author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Medicina
CTS151: Bioquímica médica
dc.subject.none.fl_str_mv Advanced
Loco-regional recurrence
Breast cancer
SEOM
Guidelines
topic Advanced
Loco-regional recurrence
Breast cancer
SEOM
Guidelines
description Although the metastasic breast cancer is still an incurable disease, recent advances have increased signifcantly the time to progression and the overall survival. However, too much information has been produced in the last 2 years, so a well-based guideline is a valuable document in treatment decision making. The SEOM guidelines are intended to make evidence-based recommendations on how to manage patients with advanced and recurrent breast cancer to achieve the best patient outcomes based on a rational use of the currently available therapies. To assign a level of certainty and a grade of recommendation the United States Preventive Services Task Force guidelines methodology was selected as reference.
publishDate 2019
dc.date.none.fl_str_mv 2019
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv https://hdl.handle.net/11441/156029
https://doi.org/10.1007/s12094-018-02010-w
url https://hdl.handle.net/11441/156029
https://doi.org/10.1007/s12094-018-02010-w
dc.language.none.fl_str_mv Inglés
language_invalid_str_mv Inglés
dc.relation.none.fl_str_mv Clinical and Translational Oncology, 21 (1), 31-45.
https://link.springer.com/article/10.1007/s12094-018-02010-w
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
application/pdf
dc.publisher.none.fl_str_mv Springer
publisher.none.fl_str_mv Springer
dc.source.none.fl_str_mv reponame:idUS. Depósito de Investigación de la Universidad de Sevilla
instname:Universidad de Sevilla (US)
instname_str Universidad de Sevilla (US)
reponame_str idUS. Depósito de Investigación de la Universidad de Sevilla
collection idUS. Depósito de Investigación de la Universidad de Sevilla
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869412956997943296
score 15,812429

Similar Items